ECOR stock information

Sector:

Healthcare

Description:

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

electroCore, Inc. website

Current Price

$4.79

RSI

15.62

Market Capitalization:

54.6M

Beta:

1.053

Volume:

11,877

Analyst Target Price:

$ 3.29

Economiic Fair Price:

Earnings DateNovember 03, 2022

Report DateNovember 03, 2022

QuarterQ3

Forward Dividend N/A

Forward Dividend Rate N/A

Dividend N/A

Dividend Rate N/A

Payout Ratio N/A

Cash21.6M

Debt716000

EPS-0.352

Profit MarginN/A

Revenue Per Share TTM0.093

Return On Equity TTM-0.531

YoY Revenue Growth (TTM)

55.28 %

YoY Pre Tax Income Growth (TTM)

-17.83 %

YoY Free Cash Flow (TTM)

-45.93 %

QoQ Revenue Growth

32.88 %

QoQ Pre Tax Income Growth

-36.84 %

QoQ Free Cash Flow Growth

-33.63 %

2021 Revenue

$ 5.5M

55.93 %

2020 Revenue

$ 3.5M

46.25 %

2019 Revenue

$ 2.4M

140.72 %

2018 Revenue

$ 993K

22.37 %

2017 Revenue

$ 811.5K

219.30 %

2016 Revenue

$ 254.1K

2021 Free Cash Flow

$ -13.6M

32.21 %

2020 Free Cash Flow

$ -20.1M

55.46 %

2019 Free Cash Flow

$ -45.1M

4.75 %

2018 Free Cash Flow

$ -47.4M

-85.97 %

2017 Free Cash Flow

$ -25.5M

-92.67 %

2016 Free Cash Flow

$ -13.2M

2021 Pre Tax Income

$ -18.1M

26.79 %

2020 Pre Tax Income

$ -24.7M

45.31 %

2019 Pre Tax Income

$ -45.1M

19.07 %

2018 Pre Tax Income

$ -55.8M

-54.77 %

2017 Pre Tax Income

$ -36M

-128.30 %

2016 Pre Tax Income

$ -15.8M

electroCore, Inc.(ECOR)